Trajectories of Nonmedical Prescription Drug Misuse
非医疗处方药滥用的轨迹
基本信息
- 批准号:9096030
- 负责人:
- 金额:$ 23.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-07-01 至 2018-05-31
- 项目状态:已结题
- 来源:
- 关键词:21 year oldAddressAdolescenceAdolescentAdolescent and Young AdultAdultAgeApplications GrantsDataDevelopmentDrug abuseEpidemiologyFutureHealthHealth ProfessionalHeterogeneityHospitalizationIndividualInvestigationKnowledgeLeadLegalLongitudinal StudiesMeasurementMeasuresMedicalMedication ManagementModelingMonitorNIH Program AnnouncementsOpioidParentsPatternPharmaceutical PreparationsPreventionRecording of previous eventsResearchResearch DesignRiskSample SizeSamplingScheduleSocioeconomic StatusSubstance Use DisorderTestingTranquilizing AgentsUnited States Substance Abuse and Mental Health Services AdministrationWorkadverse outcomeagedbaseclinical practicecohortimprovedmeetingsmisuse of prescription only drugsnonmedical useopioid useprescription drug abuseprescription opioidprospectiveresponsesedativesextheoriestwelfth gradeyoung adult
项目摘要
DESCRIPTION (provided by applicant): In response to PA-13-080: Accelerating the Pace of Drug Abuse Research Using Existing Research Data, this competing renewal "Trajectories of Nonmedical Prescription Drug Misuse" builds on our parent R01 and proposes to use multiple cohorts of nationally representative longitudinal data to assess the individual patterns and trajectories of medical and nonmedical use of four classes of prescription medications (i.e., opioids, sedatives, stimulants, tranquilizers) from adolescence to adulthood and the development of substance use disorders (SUDs) and other long-term adverse consequences in adulthood. Despite increases in the medical and nonmedical use of prescription medications among adolescents and young adults in the U.S., relatively few prospective longitudinal studies have investigated the development of SUDs and other adverse consequences in adulthood. While there have been advances in understanding nonmedical use of prescription medications and short-term consequences, considerable gaps in knowledge remain due to limitations in measurement and study designs. Findings from our parent R01 suggest a great deal of heterogeneity in the nonmedical use of prescription medications during adolescence and young adulthood (ages 18-22). The Monitoring the Future (MTF) study provides a valuable opportunity to address new research questions that will lead to a more comprehensive understanding of medical and nonmedical use of prescription medications. We propose several secondary analyses using 39 nationally representative cohorts of approximately 585,000 high school seniors between 1976 and 2014 from the MTF study. The MTF longitudinal panel sample features 23 separate cohorts of approximately 55,200 high school seniors (modal age 18) who were followed 3-4 years (modal ages 21-22), 7-8 years (modal ages 25-26), and 17 years (modal age 35) later, resulting in four longitudinal waves of data for each cohort. The MTF study represents the only nationally representative longitudinal study that has sufficient measures and sample size to test for potential sex, racial, and socioeconomic status differences and to meet the objectives of our study, which aims to: 1) assess the individual patterns and trajectories of medical and nonmedical use of four prescription medication classes (i.e., opioids, sedatives, stimulants, tranquilizers) during the transition from adolescence (age 18) to adulthood (age 35) using cross-sectional and longitudinal panel data; 2) examine the associations between individual patterns and trajectories of medical and nonmedical use of four medication classes from adolescence to adulthood and development of SUDs and other adverse consequences (e.g., health problems, hospitalizations, and legal problems) during adulthood (age 35) using longitudinal panel data; and 3) investigate the risk and protective factors for individual patterns
and trajectories of medical and nonmedical use of four prescription medication classes from adolescence to adulthood associated with development of SUDs and other consequences during adulthood (age 35) using a theory-based developmental model and longitudinal panel data.
描述(申请人提供):为响应PA-13-080:利用现有研究数据加快药物滥用研究的步伐,这一相互竞争的更新“非医疗处方药滥用的轨迹”建立在我们的母公司R01的基础上,并建议使用多个具有全国代表性的纵向数据队列来评估四类处方药(即阿片类药物、镇静剂、兴奋剂、镇静剂)从青春期到成年期的医疗和非医疗用药的个体模式和轨迹,以及成年期物质使用障碍(SUD)和其他长期不良后果的发展。尽管在美国青少年和年轻人中使用处方药的医疗和非医疗用途有所增加,但相对较少的前瞻性纵向研究调查了肥皂水症的发展和成年后的其他不良后果。虽然在理解处方药的非医疗用途和短期后果方面已经取得了进展,但由于测量和研究设计的限制,在知识方面仍然存在相当大的差距。我们的父母R01的研究结果表明,青春期和成年期(18-22岁)非医疗处方药的使用存在很大的异质性。监测未来(MTF)研究提供了一个宝贵的机会来解决新的研究问题,这将导致更全面地了解处方药的医疗和非医疗用途。我们从MTF研究中提出了几个二级分析,使用了来自MTF研究的大约585,000名高中生的39个全国代表性队列。MTF纵向面板样本包括大约55,200名高中生(18岁)的23个独立队列,他们在3-4年(模型年龄21-22岁)、7-8年(模型年龄25-26岁)和17年(模型年龄35岁)之后进行跟踪,导致每个队列的四个数据纵向波动。MTF研究代表了唯一具有全国代表性的纵向研究,具有足够的措施和样本量来测试潜在的性别、种族和社会经济地位差异,并满足我们研究的目标,其目的是:1)使用横断面和纵向小组数据评估从青春期(18岁)到成年期(35岁)期间四种处方药类别(即阿片类药物、镇静剂、兴奋剂、镇静剂)的个人模式和非医疗使用轨迹;2)使用纵向面板数据检验从青春期到成年期的四种药物类别的医疗和非医疗使用的个体模式和轨迹与成年期(35岁)期间肥皂泡的发展和其他不良后果(例如,健康问题、住院和法律问题)之间的关系;以及3)调查个体模式的风险和保护因素
以及使用基于理论的发展模型和纵向面板数据,从青春期到成年期(35岁)与肥皂泡和其他后果相关的四种处方药类别的医疗和非医疗使用轨迹。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SEAN ESTEBAN MCCABE其他文献
SEAN ESTEBAN MCCABE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SEAN ESTEBAN MCCABE', 18)}}的其他基金
Health, Stress, and Tobacco Use Disparities among Sexual Minority Populations
性少数人群的健康、压力和烟草使用差异
- 批准号:
9380175 - 财政年份:2017
- 资助金额:
$ 23.02万 - 项目类别:
E-Cigarette Use and Longitudinal Changes in Cigarette Smoking and Health
电子烟的使用以及吸烟与健康的纵向变化
- 批准号:
9339655 - 财政年份:2016
- 资助金额:
$ 23.02万 - 项目类别:
E-Cigarette Use and Longitudinal Changes in Cigarette Smoking and Health
电子烟的使用以及吸烟与健康的纵向变化
- 批准号:
9077678 - 财政年份:2016
- 资助金额:
$ 23.02万 - 项目类别:
Longitudinal Changes in Recovery from Drug Use Disorders: A National Study
吸毒障碍康复的纵向变化:一项全国研究
- 批准号:
9220789 - 财政年份:2015
- 资助金额:
$ 23.02万 - 项目类别:
Trajectories of Nonmedical Prescription Drug Misuse
非医疗处方药滥用的轨迹
- 批准号:
8233989 - 财政年份:2011
- 资助金额:
$ 23.02万 - 项目类别:
Trajectories of Nonmedical Prescription Drug Misuse
非医疗处方药滥用的轨迹
- 批准号:
8445325 - 财政年份:2011
- 资助金额:
$ 23.02万 - 项目类别:
Trajectories of Nonmedical Prescription Drug Misuse
非医疗处方药滥用的轨迹
- 批准号:
9908065 - 财政年份:2011
- 资助金额:
$ 23.02万 - 项目类别:
Trajectories of Nonmedical Prescription Drug Misuse
非医疗处方药滥用的轨迹
- 批准号:
8083034 - 财政年份:2011
- 资助金额:
$ 23.02万 - 项目类别:
Sexual Orientation, Substance Use and Mental Health
性取向、药物滥用和心理健康
- 批准号:
7384322 - 财政年份:2007
- 资助金额:
$ 23.02万 - 项目类别:
Sexual Orientation, Substance Use and Mental Health
性取向、药物滥用和心理健康
- 批准号:
7501921 - 财政年份:2007
- 资助金额:
$ 23.02万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 23.02万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 23.02万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 23.02万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 23.02万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 23.02万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 23.02万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 23.02万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 23.02万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 23.02万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 23.02万 - 项目类别:
Research Grant